THE INNOVATIVE MEDICINES INITIATIVE

The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.

IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.

IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.

EU Logoefpia Logo

 

IMI 9TH CALL FOR PROPOSALS

Topics under consideration for IMI's 9th Call for proposals are:

  • Leveraging technologies for pharmacovigilance
  • Physical frailty and sarcopenia
  • Developing drug-drug combinations
  • Antimicrobial resistance (two topics)

ONGOING PROJECTS

  • Action on autism

    EU-AIMS is developing tools that will help us to boost our understanding of autism spectrum disorders, paving the way for new treatments

    ... more
  • Diabetes treatment gets personal

    DIRECT is identifying different subtypes of type 2 diabetes to determine the most appropriate treatments for them

    ... more
  • Get on-course!

    EMTRAIN officially launches on-course - with over 4 200 courses, it's Europe's most comprehensive biomedical R&D postgrad course portal

    ... more
  • Innovation in action

    IMI supports 40 projects with a combined budget of €1.2 billion covering drug safety & efficacy, knowledge management, and education &... more

  • Liver-friendly drugs

    MIP-DILI is developing tests to help detect liver toxicity problems early in development, saving many patients from the trauma of liver failure

    ... more
  • Patient power!

    EUPATI is developing educational resources that will empower patients to engage more effectively in the drug research and development process

    ... more
  • Taking on TB

    PreDiCT-TB is speeding up the search for new, more effective combinations of treatments to tackle the deadly disease tuberculosis (TB)

    ... more
  • Towards safer drugs

    ABIRISK is boosting the safety of biopharmaceuticals, novel drugs that have already proven effective at treating certain serious conditions.

    ... more
  • Vaccine safety

    BIOVACSAFE is developing cutting edge tools to speed up and improve the testing and monitoring of vaccine safety

    ... more
All projects

SIGN UP FOR IMI'S INFO SESSION IN BARCELONA

Registration is open for IMI's info session on 28 June in Barcelona, Spain.

  • IMI's rules and procedures
  • Tips on preparing a successful proposal
  • Overview of Call topics

more

IMI NEWSFLASH IMI News Flash

 
  • 19/06/2013 : RT @EFPIA: Learn more about the Innovative Medicines Initiative on the EFPIA website @IMI_JU #innovation - http://t.co/pZ0Hfu2Jy1
  • 19/06/2013 : RT @DDMoRe_IMI: At PAGE, Nick Holford and Mike K Smith presented: MDL - The DDMoRe modelling description language, also available at http:/…
  • 18/06/2013 : RT @eTRIKS1: A sad truth about all the translational research data that is being collected. http://t.co/J2jFxHy0Gk

Follow us on Twitter